GOSS (Gossamer Bio) FCF Margin %: -228.38% (As of Mar. 2026)


GOSS Gossamer Bio Inc GOSS
16 GF Score
Price $0.17
! 5 Warning Signs
View Full Analysis

What is Gossamer Bio FCF Margin %?

Gossamer Bio GOSS -2.82% 16 FCF Margin % is -228.38% as of Mar. 2026. GuruFocus rates GOSS with a GF Score™ of 16/100. The stock has 5 warning signs investors should review. Among 959 Biotechnology companies, Gossamer Bio ranks worse than 65.17% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Gossamer Bio's Free Cash Flow for the three months ended in Mar. 2026 was $-38.72 Mil. Gossamer Bio's Revenue for the three months ended in Mar. 2026 was $16.96 Mil. Therefore, Gossamer Bio's FCF Margin % for the quarter that ended in Mar. 2026 was -228.38%.

As of today, Gossamer Bio's current FCF Yield % is -206.52%.

The historical rank and industry rank for Gossamer Bio's FCF Margin % or its related term are showing as below:

GOSS' s FCF Margin % Range Over the Past 10 Years
Min: -353.5   Med: -178.26   Max: -3.02
Current: -306.67

During the past 10 years, the highest FCF Margin % of Gossamer Bio was -3.02%. The lowest was -353.50%. And the median was -178.26%.

GOSS's FCF Margin % is ranked worse than
65.17% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs GOSS: -306.67

Gossamer Bio FCF Margin % Related Terms

Gossamer Bio FCF Margin % Historical Data

* Premium members only.

The historical data trend for Gossamer Bio's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gossamer Bio FCF Margin % Chart

Gossamer Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -3.02 -353.50

Gossamer Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -401.96 -410.08 -272.06 -350.13 -228.38

GOSS vs TIL, ATYR, HYPD: FCF Margin % Comparison

For the Biotechnology subindustry, Gossamer Bio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gossamer Bio FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gossamer Bio's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Gossamer Bio's FCF Margin % falls into.


GOSS
16GF Score
Gossamer Bio Inc GOSS
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gossamer Bio FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Gossamer Bio's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-171.345/48.471
=-353.50 %

Gossamer Bio's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-38.721/16.955
=-228.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -228.38% mean?
Gossamer Bio (GOSS) has a FCF Margin % of -228.38% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Gossamer Bio and its competitors. According to the industry distribution chart, Gossamer Bio ranks #625 out of 959 companies in the Biotechnology industry, placing it in the top 65.2%.
Is Gossamer Bio's FCF Margin % too high?
Gossamer Bio's current FCF Margin % is -228.38%. Based on the distribution chart, Gossamer Bio ranks #625 out of 959 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Gossamer Bio has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Gossamer Bio's FCF Margin % compare to TIL and ATYR?
According to the Biotechnology industry distribution chart, Gossamer Bio ranks #625 out of 959 companies for FCF Margin %. This places Gossamer Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Gossamer Bio and its competitors. Gossamer Bio's current FCF Margin % is -228.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gossamer Bio stock overvalued right now?
Gossamer Bio (GOSS) has a current FCF Margin % of -228.38%. The current FCF Margin % is -228.38%. Gossamer Bio's overall GF Score™ is 16/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Gossamer Bio (GOSS), the current FCF Margin % is -228.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gossamer Bio Business Description

Other Exchanges 4GB:Germany
Address 3115 Merryfield Row, Suite 120, San Diego, CA, USA, 92121
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
16GF Score

Get the complete analysis for GOSS

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.17
Price